Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. nightwatch

NIGHTWATCH SIGNED

NightWatch - Clinically-proven detection and alert system for critical nocturnal epileptic seizures.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NIGHTWATCH project word cloud

Explore the words cloud of the NIGHTWATCH project. It provides you a very rough idea of what is the project "NIGHTWATCH" about.

leads    full    self    few    28    independency    caused    4    societal    notifies    specialised    spin    seek    anxiety    lack    wirelessly    90    ai    sleep    wearables    false    billion    monitor    die    reduces    professionals    patients    gt    registered    patterns    combination    critical    mind    50m    caregivers    tested    bracelet    intramural    heavy    preferred    heart    giving    unexpected    peace    america    medical    device    2019    automatically    clinically    algorithm    least    suffer    trend    prevented    company    relief    home    dutch    remote    flagship    2013    uses    off    seconds    market    minimize    46    tele    detects    life    followed    depression    continuous    more    commercial    detect    sudep    seizure    urgent    alarm    profit    monitoring    pushing    wards    nightwatch    nocturnal    time    accumulated    north    created    death    prevents    deaths    despite    epilepsy    livassured    improves    seizures    uncontrolled    rate    care    roi    adapting    attending    worldwide    types    conceived    30    quality    movement    patient    severe    medication    people    sudden    social    33    institutes    40    19m    reducing   

Project "NIGHTWATCH" data sheet

The following table provides information about the project.

Coordinator		 LIVASSURED BV 

Organization address
address: ALBERTUSSTRAAT 34
city: VUGHT
postcode: 5261AD
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIVASSURED BV NL (VUGHT) coordinator 50˙000.00

Map

 Project objective

More than 50M people worldwide suffer from epilepsy, characterized by uncontrolled seizures, and about 30% find no relief from those despite taking medication. Nocturnal seizures can be critical; each year at least 33.000 people in EU die of Sudden Unexpected Death in Epilepsy (SUDEP), 40% of which could be prevented by attending the seizures on time. This is a continuous challenge for patients and caregivers, with important social and societal consequences (anxiety, depression, lack of sleep), and high intramural care costs (over €20 billion per year in EU). The NightWatch is a registered medical device that detects and notifies wirelessly remote caregivers in case of heavy nocturnal seizures in just few seconds. The bracelet uses a combination of heart rate and movement measurement, a unique AI algorithm conceived by three Dutch institutes specialised in epilepsy, automatically adapting to different patient patterns to minimize false alarm rate. It has been clinically tested and can detect > 90% of all types of urgent nocturnal seizures making it the most reliable system available. The NightWatch targets caregivers, patients and professionals who seek an effective alarm system for severe nocturnal seizures. It improves their quality of life giving them peace of mind, higher level of independency, reduces cost of care by reducing the need for intramural attention, and prevents deaths caused by SUDEP. With a trend to-wards home care and self-monitoring pushing market growth (expected to reach €4.0 billion in 2019), wearables becoming the preferred type of seizure monitoring. EU leads the seizure monitor devices market (46%), followed by North America (28%). NightWatch is the flagship product of LivAssured, a Dutch company created in 2013 as a spin-off to take over the commercial exploitation of the research results of the Tele-Epilepsy Consortium on nocturnal seizures. With its full commercial exploitation, we expect an accumulated profit of €19M and a ROI of 4

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NIGHTWATCH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NIGHTWATCH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

Primavera (2018)

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Read More